Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxybutynin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 6/20 | 0.98 |
| ▸ | CHRM3 known ✓ | P20309 | 4/20 | 0.98 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.98 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.98 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.98 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.98 |
| ▸ | PKM | P14618 | 1/20 | 0.98 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.98 |
| ▸ | THPO | P40225 | 1/20 | 0.98 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.98 |
| ▸ | ESR1 | P03372 | 1/20 | 0.98 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.98 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.98 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.98 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxybutynin SCHEMBL1560964 | 0.99 | CHRM2 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL2992 | 0.99 | CHRM2 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Esoxybutynin SCHEMBL290373 | 0.99 | CHRM2 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Aroxybutynin SCHEMBL25880 | 0.99 | CHRM2 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL25751 | 0.98 | MEN1 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL8019436 | 0.98 | MEN1 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL19816026 | 0.98 | CHRM2 (0.98) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL7895841 | 0.98 | CHRM2 (0.98) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL5494388 | 0.98 | MEN1 (1.00) | CHRM2CHRM1CHRM4CHRM3KCNH2 | |
| Oxybutynin SCHEMBL7557853 | 0.98 | CHRM2 (0.98) | CHRM2CHRM1CHRM4CHRM3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1435915-B1 | ORAL DOSAGE FORMS FOR PROPIVERINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT | APOGEPHA ARZNEIMITTEL GMBH (DE) | 2008-07-23 | — | — | EP | disclosed |
| EP-1435915-A1 | ORAL DOSAGE FORM FOR PROPIVERINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT | APOGEPHA ARZNEIMITTEL GmbH (DE) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003030869-A1 | ORAL DOSAGE FORM FOR PROPIVERINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT | APOGEPHA ARZNEIMITTEL GMBH (DE) | 2003-04-17 | — | — | WO | disclosed |